Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose dexamethasone for total knee arthroplasty
NCT03758170Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- Jan 2019
- Primary completion
- Feb 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexamethasone in postoperative pain and postoperative nausea and vomiting (PONV), sponsored by Rigshospitalet. Started Jan 2019; status: completed.
02
Drugs
dexamethasone
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT03758170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03758170.